Providers Added to the Database Updates
  • Avast, the parent company of Jumpshot, a web traffic provider, estimates the addressable market for its Jumpshot business at $2.8b by 2021 (Prospectus, p. 57). Avast IPO'd this week. (Reuters)
  • YipitData launched web-scraping based product to track key performance metrics for China Lodging Group (HTHT), including occupancy rates, ADR, and RevPAR. (Request Info)
  • 7Park Data raised 7mm in new funding. (SEC)
  • iSentium, a sentiment provider, hired Ray Tierney III (former head of trading at Morgan Stanley and Bloomberg Tradebook) as president and COO. (efinancialcareers)
Jobs
Events
  • Discovery Day Intrepid - BattleFin (New York, June 20) -AlternativeData.org is a media partner for the event - use discount code "AltData20" to receive 20% off your ticket. 
News & Insights
  • Buy-side spend on alternative datasets has significantly accelerated over the last two years (~60% y/y) and is estimated to reach over $1bn by 2020. (Financial TimesAlternativeData.org)
  • Goldman Sachs gearing up to sell internal data. Potential product could include trade and pricing data at high frequencies, leveraging role as over-the-counter dealmaker. (Risk.netsubscription required)
  • Market for geo-location data grows with increasingly inventive use cases, but technical challenges remain.
    • Market for geo-location data expected to grow to $250mm by 2020, according to new report from Opimas, a capital markets consultancy. (marketsmediaFull Report)
    • Schroders data science unit used geo-location data to assess a pizza-chain expansion plan based on casual dining competition and foot traffic. (Pensions & Investments)
    • Still, the data requires expert validation before it can be put to use. “In one case, there was data that showed peak visitors in a Home Depot in California ... (came) at 8 a.m. The store opened at 10 a.m. But that store has a loading dock that abuts a freeway.” - Michael Recce, Chief Data Scientist, Neuberger Berman. (Pensions & Investments)
  • Washington Post op-ed theorizes on a potential regulation for companies to release their data to the public after a few years, in a model similar to drug patents. (Washington Post)